LATEST UPDATES » Vol 25, No. 01, January 2021 – Home-Based Diagnostic Testing: Revolutionizing IBD Treatment       » Study Reveals Understanding of China’s Carbon Emission Balance       » Developing Nanomaterials for Better Performance       » Helping Farmers Monitor Plant Health and Improve Crop Yield       » Protecting the Brain through Gut-Trained Immune Cells       » Using Machine Learning to Predict Anti-Cancer Drug Efficacy      
Vol 25, No. 01, January 2021   |   Issue PDF view/purchase
New Partnership to Bring Premium Stem Cell Treatments to Phuket
Thanyapura Sports and Health Resort, Phuket has partnered with StemCells21 (SC21), a medical biotech company based in Bangkok, Thailand, to offer premium stem cell treatments for various degenerative diseases, immune disorders, injuries and anti-ageing.

Located on the island of Phuket, Thanyapura Sports and Health Resort is an active holiday destination with personalized programs from sports, fitness, nutrition and lifestyle medicine for both individuals and groups. Together with over a decade of clinical history and an experienced team, SC21 combines 21st-century cellular medicine and cutting-edge supportive therapies to offer the highest quality stem cell treatments with Mesenchymal Stem Cells (MSCs) and Induced Pluripotent Stem Cells (iPSCs).

In the first of its kind in Phuket, this partnership will offer premium stem cell treatments for various degenerative diseases, immune disorders, injuries and anti-ageing. The treatments can also tackle a host of medical problems such as type 2 diabetes, osteoarthritis, chronic back pain and inflammatory lung diseases such as asthma and bronchitis, as well as strengthen body immunity and improve fertility.

Regenerative medicine has been regarded as part of the sporting world which can help in optimising the human body to perform at a higher level. It also allows effective treatment of sport injuries through faster healing, reduced injury inflammation and regeneration of injured tissue. The human-based regenerative therapy has been successful with high calibre athletes for endurance enhancement and lengthening professional careers by reducing injury rates.

Guests are able book a free dedicated one-on-one consultation with a certified stem cell specialist for their first session. Those seeking longer-term treatments can book a discounted stay at Thanyapura to utilise its world-class facilities, award-winning vegan and vegetarian restaurants and lifestyle clinic.

Speaking about the new venture, President & CEO of Thanyapura World, Philipp Graf von Hardenberg said, "We are excited to be working with SC21 to facilitate their first clinic outside of Bangkok and deliver world-class treatment to guests and members at Thanyapura. This partnership really supports in putting us on the global stage as a leading lifestyle optimisation destination in the sports and lifestyle industry."

Treatment packages can be customised from the number of Premium Grade (P1) MSCs to the treatment duration and include supportive therapies from a comprehensive health check-up to the highest standards of after-care services. Thanyapura’s 360 approach will help in delivering better, longer-lasting outcomes for challenging conditions that conventional therapies often fail to address, such as stopping disease progression, as well as avoiding surgical intervention.

"Stem cell therapy is a tool to optimise the human body to perform at a higher level, and we want to make the environment of the body less hazardous and more harmonious for repair and regeneration," said Paul Collier, Founder and Managing Partner of SC21. "SC21 was founded to provide treatments that few people know are available, and to offer health outcomes that are superior to what most thought possible, and we are looking forward to bringing our experience and expertise to Thanyapura."

news Highlights from the E&L China 2020 Conference
news Asia’s ageing population drives development of rehabilitation technologies targeting elderly disabilities
news Virtual Expo Connect to empower access for international pharma to the world’s largest pharma ingredients market
news WEIPU, AstraZeneca, Huadong Medicine, Saint-Gobain, Baxter, Wuxi AppTec, Henlius, Medtronic and more confirmed to speak at E&L China this December

About Us
Available issues
Editorial Board
Letters to Editor
Contribute to APBN
Advertise with Us
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Deborah Seah
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
Copyright© 2021 World Scientific Publishing Co Pte Ltd  •  Privacy Policy